If You Invested in NeuBase Therapeutics, Inc. (NBSE)
See the NBSE overviewWhat $1,000 or $10,000 in NBSE Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Nov 3, 2015 |
|---|---|---|---|---|
| $1,000 | $95 -90% | $6.22 -99% | — | $0.31 -99.97% |
| $10,000 | $951 -90% | $62 -99% | — | $3.07 -99.97% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-05-24. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for NBSE$1,000 Investment Over Time
NBSE vs S&P 500Year-by-Year Returns
NBSE annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015Nov 3, 2015 to Dec 31, 2015 | $1,230.00 | $2,456.00 | +99.7% | +99.7% |
| 2016 | $2,456.00 | $600.00 | -75.6% | -51.2% |
| 2017 | $600.00 | $744.00 | +24.0% | -39.5% |
| 2018 | $744.00 | $34.40 | -95.4% | -97.2% |
| 2019 | $34.40 | $144.00 | +318.6% | -88.3% |
| 2020 | $144.00 | $139.80 | -2.9% | -88.6% |
| 2021 | $139.80 | $56.20 | -59.8% | -95.4% |
| 2022 | $56.20 | $3.80 | -93.2% | -99.7% |
| 2023 | $3.80 | $0.7401 | -80.5% | -99.9% |
| 2024Dec 29, 2023 to May 24, 2024 | $0.7401 | $0.3780 | -48.9% | -99.97% |
About NeuBase Therapeutics, Inc.
NASDAQ
Frequently Asked Questions
NeuBase Therapeutics, Inc. investment returns
How much was $1,000 invested in NeuBase Therapeutics, Inc. worth at its last close?
If you invested $1,000 in NeuBase Therapeutics, Inc. (NBSE) 5 years before its last close, on 2019-05-24, your investment was worth $6.22 on 2024-05-24, a -99.4% price return without dividends, growing at a compounded rate of -63.8% per year (CAGR).
Has NeuBase Therapeutics, Inc. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare NBSE performance over available time periods.
What is NeuBase Therapeutics, Inc.'s average annual return?
The compound annual growth rate (CAGR) of NBSE’s share price over the 5 years to May 24, 2024 is -63.8%, without dividends. Individual years vary a great deal, and NBSE’s best recent full year was 2019 (+318.6%) while the worst was 2018 (-95.4%).
For informational and educational purposes only, not investment advice.
